Your request to link to rcsb for SUMO1/SENP2

• 1TGZ: structure of human senp2 in complex with sumo-1 (10.1016/J.STR.2004.05.023 )
• 1TH0: structure of human senp2 (10.1016/J.STR.2004.05.023 )
• 1WYW: crystal structure of sumo1-conjugated thymine dna glycosylase (10.1038/NATURE03634 )
• 1Y8R: sumo e1 activating enzyme sae1-sae2-sumo1-mg-atp complex (10.1038/SJ.EMBOJ.7600552 )
• 1Z5S: crystal structure of a complex between ubc9, sumo-1, rangap1 and nup358/ranbp2 (10.1038/NATURE03588 )
• 2ASQ: solution structure of sumo-1 in complex with a sumo-binding motif (sbm) (10.1074/JBC.M507059200 )
• 2BF8: crystal structure of sumo modified ubiquitin conjugating enzyme e2-25k (10.1038/NSMB903 )
• 2G4D: crystal structure of human senp1 mutant (c603s) in complex with sumo-1 (10.1042/BJ20060526 )
• 2IO0: crystal structure of human senp2 in complex with presumo-2 (10.1038/NSMB1168 )
• 2IO1: crystal structure of human senp2 in complex with presumo-3 (10.1038/NSMB1168 )
• 2IO2: crystal structure of human senp2 in complex with rangap1-sumo-1 (10.1038/NSMB1168 )
• 2IO3: crystal structure of human senp2 in complex with rangap1-sumo-2 (10.1038/NSMB1168 )
• 2IY0: senp1 (mutant) sumo1 rangap (10.1038/NSMB1172 )
• 2IY1: senp1 (mutant) full length sumo1 (10.1038/NSMB1172 )
• 2KQS: phosphorylation of sumo-interacting motif by ck2 enhances daxx sumo binding activity (10.1016/J.MOLCEL.2011.02.022 )
• 2LAS: molecular determinants of paralogue-specific sumo-sim recognition (10.1074/JBC.M111.293118 )
• 2MW5: backbone fold of human small ubiquitin like modifier protein-1 (sumo- 1) based on prot3d-nmr approach.
• 2N1A: docked structure between sumo1 and zz-domain from cbp (10.1074/JBC.M115.711325 )
• 2N1V: solution structure of human sumo1
• 2PE6: non-covalent complex between human sumo-1 and human ubc9 (10.1016/J.JMB.2007.04.006 )
• 2UYZ: non-covalent complex between ubc9 and sumo1 (10.1038/SJ.EMBOJ.7601711 )
• 2VRR: structure of sumo modified ubc9 (10.1016/J.MOLCEL.2008.05.022 )
• 3KYC: human sumo e1 complex with a sumo1-amp mimic (10.1038/NATURE08765 )
• 3KYD: human sumo e1~sumo1-amp tetrahedral intermediate mimic (10.1038/NATURE08765 )
• 3RZW: crystal structure of the monobody ysmb-9 bound to human sumo1 (10.1016/J.JMB.2011.12.019 )
• 3UIP: complex between human rangap1-sumo1, ubc9 and the ir1 domain from ranbp2 containing ir2 motif ii (10.1074/JBC.M111.321141 )
• 3ZO5: structure of senp2-loop1 in complex with presumo-2 (10.1002/PRO.2425 )
• 4WJN: crystal structure of sumo1 in complex with phosphorylated pml (10.1016/J.STR.2014.10.015 )
• 4WJO: crystal structure of sumo1 in complex with pml (10.1016/J.STR.2014.10.015 )
• 4WJP: crystal structure of sumo1 in complex with phosphorylated daxx (10.1016/J.STR.2014.10.015 )
• 4WJQ: crystal structure of sumo1 in complex with daxx (10.1016/J.STR.2014.10.015 )
• 5AEK: crystal structure of the human senp2 c548s in complex with the human sumo1 k48m f66w
• 5B7A: solution structure of lys37 acetylated human sumo1
• 5ELJ: isoform-specific inhibition of sumo-dependent protein-protein interactions (10.1126/SCISIGNAL.AAJ2005 )
• 5GHD: solution structure of lys39 acetylated human sumo1
• 6J4I: a conserved and buried edge-to-face aromatic interaction in sumo is vital for the sumo pathway (10.1074/JBC.RA118.006642 )
• 6JXU: sumo1 bound to sls4-sim peptide from icp0 (10.1016/J.JMB.2020.01.021 )
• 6JXV: sumo1 bound to phosphorylated sls4-sim peptide from icp0 (10.1016/J.JMB.2020.01.021 )
• 6K5T: complex of sumo1 and phosphorylated hcmv protein ie2 (10.1074/JBC.RA119.009601 )
• 6UYO: crystal structure of k37-acetylated sumo1 in complex with pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYP: crystal structure of k39-acetylated sumo1 in complex with pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYQ: crystal structure of k45-acetylated sumo1 in complex with pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYR: crystal structure of k46-acetylated sumo1 in complex with pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYS: crystal structure of k37-acetylated sumo1 in complex with phosphorylated pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYT: crystal structure of k39-acetylated sumo1 in complex with phosphorylated pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYU: crystal structure of k45-acetylated sumo1 in complex with phosphorylated pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYV: crystal structure of k46-acetylated sumo1 in complex with phosphorylated pml-sim (10.1016/J.STR.2019.11.019 )
• 6UYX: crystal structure of k37-acetylated sumo1 in complex with phosphorylated daxx (10.1016/J.STR.2019.11.019 )
• 6UYY: crystal structure of k39-acetylated sumo1 in complex with phosphorylated daxx (10.1016/J.STR.2019.11.019 )
• 6UYZ: crystal structure of k46-acetylated sumo1 in complex with phosphorylated daxx (10.1016/J.STR.2019.11.019 )
• 6V7P: crystal structure of sumo1 in complex with pias-sim2 (10.1016/J.STR.2020.04.002 )
• 6V7Q: crystal structure of sumo1 in complex with phosphorylated pias-sim2 (10.1016/J.STR.2020.04.002 )
• 6V7R: crystal structure of k37-acetylated sumo1 in complex with pias-sim2 (10.1016/J.STR.2020.04.002 )
• 6V7S: crystal structure of k37-acetylated sumo1 in complex with phosphorylated pias-sim2 (10.1016/J.STR.2020.04.002 )
• 6XOG: structure of sumo1-ml786519 adduct bound to sae (10.1021/ACS.JMEDCHEM.0C01491 )
• 6XOH: structure of sumo1-ml00789344 adduct bound to sae (10.1021/ACS.JMEDCHEM.0C01491 )
• 6XOI: structure of sumo1-ml00752641 adduct bound to sae (10.1021/ACS.JMEDCHEM.0C01491 )